These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
3. Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed? Stellini R; Gianello R; Gomarasca W Infection; 2022 Dec; 50(6):1573-1577. PubMed ID: 35391649 [TBL] [Abstract][Full Text] [Related]
4. Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern. Kumar NP; Banurekha VV; Kumar CPG; Nancy A; Padmapriyadarsini C; Shankar S; Hanna LE; Murhekar M; Devi KRU; Babu S J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35900009 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination. Pezzati L; Milazzo L; Carrozzo G; Kullmann C; Oreni L; Beltrami M; Caronni S; Lai A; Caberlotto L; Ottomano C; Antinori S; Ridolfo AL J Infect Chemother; 2023 Jun; 29(6):624-627. PubMed ID: 36914095 [TBL] [Abstract][Full Text] [Related]
6. Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting. Batra G; Murugesan DR; Raghavan S; Chattopadhyay S; Mehdi F; Ayushi ; Gosain M; Singh S; Das SJ; Deshpande S; Sonar S; Jakhar K; Bhattacharya J; Mani S; Pandey AK; Sankalp ; Goswami S; Das A; Dwivedi T; Sharma N; Kumar S; Sharma P; Kapoor S; Kshetrapa P; Wadhwa N; Thiruvengadam R; Kumar R; Gupta R; Garg PK; Bhatnagar S Indian J Med Res; 2023 Jun; 157(6):509-518. PubMed ID: 37322634 [TBL] [Abstract][Full Text] [Related]
8. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers. Padoan A; Cosma C; Della Rocca F; Barbaro F; Santarossa C; Dall'Olmo L; Galla L; Cattelan A; Cianci V; Basso D; Plebani M Clin Chem Lab Med; 2022 Jun; 60(7):1110-1115. PubMed ID: 35473824 [TBL] [Abstract][Full Text] [Related]
9. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390 [TBL] [Abstract][Full Text] [Related]
10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
11. Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19. Servian CDP; Spadafora-Ferreira M; Dos Anjos DCC; Guilarde AO; Gomes-Junior AR; Borges MASB; Masson LC; Silva JMM; de Lima MHA; Moraes BGN; Souza SM; Xavier LE; de Oliveira DCA; Batalha-Carvalho JV; Moro AM; Bocca AL; Pfrimer IAH; Costa NL; Feres VCR; Fiaccadori FS; Souza M; Gardinassi LG; Durigon EL; Romão PRT; Jorge SAC; Coelho V; Botosso VF; Fonseca SG Front Immunol; 2023; 14():1206979. PubMed ID: 37876932 [TBL] [Abstract][Full Text] [Related]
12. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination. Young BE; Seppo AE; Diaz N; Rosen-Carole C; Nowak-Wegrzyn A; Cruz Vasquez JM; Ferri-Huerta R; Nguyen-Contant P; Fitzgerald T; Sangster MY; Topham DJ; Järvinen KM JAMA Pediatr; 2022 Feb; 176(2):159-168. PubMed ID: 34757387 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis. Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D Front Immunol; 2022; 13():846753. PubMed ID: 35309297 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort. Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L Front Immunol; 2022; 13():829665. PubMed ID: 35154152 [TBL] [Abstract][Full Text] [Related]
15. Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers. Sarrigeorgiou I; Moschandreou D; Dimitriadis A; Tsinti G; Sotiropoulou E; Ntoukaki E; Eliadis P; Backovic M; Labropoulou S; Escriou N; Pouliakis A; Giannopoulou G; Gaitanarou E; Lazaridis K; Mentis A; Mamalaki A; Grouzi E; Lymberi P PLoS One; 2022; 17(11):e0277827. PubMed ID: 36409702 [TBL] [Abstract][Full Text] [Related]
16. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine]. Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239 [TBL] [Abstract][Full Text] [Related]
17. Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers. Salvagno GL; Henry BM; di Piazza G; Pighi L; de Nitto S; Bragantini D; Gianfilippi GL; Lippi G J Med Biochem; 2021 Sep; 40(4):327-334. PubMed ID: 34616222 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection. Abou-Saleh H; Abo-Halawa BY; Younes S; Younes N; Al-Sadeq DW; Shurrab FM; Liu N; Qotba H; Al-Dewik N; Ismail A; Yassine HM; Abu-Raddad LJ; Nasrallah GK J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36342115 [TBL] [Abstract][Full Text] [Related]
19. Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine. Pitcovski J; Gruzdev N; Abzach A; Katz C; Ben-Adiva R; Brand-Shwartz M; Yadid I; Ratzon-Ashkenazi E; Emquies K; Israeli H; Haviv H; Rapoport I; Bloch I; Shadmon R; Eitan Z; Eliahu D; Hilel T; Laster M; Kremer-Tal S; Byk-Tennenbaum T; Shahar E Vaccine; 2022 Feb; 40(8):1098-1107. PubMed ID: 35078662 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response. Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H Microbiol Spectr; 2022 Dec; 10(6):e0271622. PubMed ID: 36219096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]